Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma.

A Phase I/II Trial of BNC105P with Everolimus in Metastatic Renal Cell Carcinoma. Clin Cancer Res. 2015 Aug 01; 21(15):3420-7.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.